Law360, New York (November 4, 2015, 6:17 PM EST) -- Alexion Pharmaceuticals Inc. on Monday said the U.S. Department of Justice and U.S. Securities and Exchange Commission are investigating the company for possible violations of the Foreign Corrupt Practices Act.
In a filing with the SEC, the pharmaceutical company said the DOJ has requested documentation and information regarding its compliance with the law. The SEC's investigation into Alexion's compliance with the FCPA had been disclosed in May.
Alexion has said that it was subpoenaed by the SEC's enforcement division on May 8, requesting information on its FCPA compliance and grant-making activities. That subpoena specifically named Japan, Brazil, Turkey and Russia, but applies to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!